BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25072257)

  • 1. The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer.
    Hemdan T; Lindén M; Lind SB; Namuduri AV; Sjöstedt E; de Ståhl TD; Asplund A; Malmström PU; Segersten U
    Br J Cancer; 2014 Sep; 111(6):1180-7. PubMed ID: 25072257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy.
    Wosnitzer MS; Domingo-Domenech J; Castillo-Martin M; Ritch C; Mansukhani M; Petrylack DP; Benson MC; McKiernan JM; Cordon-Cardo C
    J Urol; 2011 Nov; 186(5):2094-100. PubMed ID: 21944130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinoma.
    Ni PZ; He JZ; Wu ZY; Ji X; Chen LQ; Xu XE; Liao LD; Wu JY; Li EM; Xu LY
    Oncol Rep; 2017 Dec; 38(6):3608-3618. PubMed ID: 29039594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
    Zhao C; Li H; Wang L; Sun W
    Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phosphorylation-specific association of STMN1 with GRP78 promotes breast cancer metastasis.
    Kuang XY; Jiang HS; Li K; Zheng YZ; Liu YR; Qiao F; Li S; Hu X; Shao ZM
    Cancer Lett; 2016 Jul; 377(1):87-96. PubMed ID: 27130664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
    Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
    Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer.
    Nie W; Xu MD; Gan L; Huang H; Xiu Q; Li B
    Lab Invest; 2015 Jan; 95(1):56-64. PubMed ID: 25384122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma.
    Bao P; Yokobori T; Altan B; Iijima M; Azuma Y; Onozato R; Yajima T; Watanabe A; Mogi A; Shimizu K; Nagashima T; Ohtaki Y; Obayashi K; Nakazawa S; Bai T; Kawabata-Iwakawa R; Asao T; Kaira K; Nishiyama M; Kuwano H
    Ann Surg Oncol; 2017 Dec; 24(13):4017-4024. PubMed ID: 28933054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated STMN1 promotes tumor growth and invasion in endometrial carcinoma.
    He X; Liao Y; Lu W; Xu G; Tong H; Ke J; Wan X
    Tumour Biol; 2016 Jul; 37(7):9951-8. PubMed ID: 26815505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours.
    Dos Santos Passaia B; Lima K; Kremer JL; da Conceição BB; de Paula Mariani BM; da Silva JCL; Zerbini MCN; Fragoso MCBV; Machado-Neto JA; Lotfi CFP
    Invest New Drugs; 2020 Jun; 38(3):899-908. PubMed ID: 31441020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration in Ovarian Cancer.
    Nie L; Zhang C; Song H; Zhao Q; Cheng L; Zhang P; Yang X
    Dis Markers; 2022; 2022():3554100. PubMed ID: 35186166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.
    Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A
    Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
    Chakravarthi BVSK; Chandrashekar DS; Agarwal S; Balasubramanya SAH; Pathi SS; Goswami MT; Jing X; Wang R; Mehra R; Asangani IA; Chinnaiyan AM; Manne U; Sonpavde G; Netto GJ; Gordetsky J; Varambally S
    Mol Cancer Res; 2018 Jul; 16(7):1125-1137. PubMed ID: 29025958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
    Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
    J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker.
    Tan HT; Wu W; Ng YZ; Zhang X; Yan B; Ong CW; Tan S; Salto-Tellez M; Hooi SC; Chung MC
    J Proteome Res; 2012 Feb; 11(2):1433-45. PubMed ID: 22181002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer.
    Kang W; Tong JH; Chan AW; Lung RW; Chau SL; Wong QW; Wong N; Yu J; Cheng AS; To KF
    PLoS One; 2012; 7(3):e33919. PubMed ID: 22470493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
    Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
    Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
    Eltze E; Wild PJ; Wülfing C; Zwarthoff EC; Burger M; Stoehr R; Korsching E; Hartmann A
    Eur Urol; 2009 Nov; 56(5):837-45. PubMed ID: 18945538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway.
    Jiang W; Huang S; Song L; Wang Z
    Oncol Rep; 2018 Feb; 39(2):834-842. PubMed ID: 29251330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.